SkillAgentSearch skills...

adme-property-predictor

Predict ADME (Absorption, Distribution, Metabolism, Excretion) properties

Install / Use

npx skills add LeoYeAI/openclaw-master-skills --skill adme-property-predictor

Installs into whichever agent you are using.

About this skill
📄

SKILL.md

Installable skill definition

Quality Score

87/100

Supported Platforms

Universal

Tags

Our assessment of adme-property-predictor

adme-property-predictor scores 87/100 on our quality scale, 22nd of 47 Healthcare & Life Sciences skills we index (top 47%).

Its SKILL.md is 23 KB long, well organised into 40 sections with 10 code examples: a thorough specification that gives an agent plenty to work with.

With 2,149 GitHub stars, it is one of the more widely adopted skills in the catalogue.

Substance
30/30
Structure
20/20
Description
12/15
Adoption
14/20
Freshness
11/15

Maintenance, license and trust

  • The repository was last updated about 4 months ago. That is recent enough to be usable, but agent tooling moves fast, so check the instructions against your agent's current version.
  • Our last check on 2026-11-02 found the source still online.
  • It is released under the MIT license, a permissive license that allows use, modification and commercial use with attribution.
  • Its trust signals score 98/100, with no cautions. These come from repository metadata, not a code audit — read the skill file before letting an agent act on it.

Safety scan

No issues found

Our scan of the whole file found no instruction hijacking, hidden characters, credential access, data exfiltration or destructive commands. An AI review of the same text found nothing harmful.

AI review by kimi-k2.7-code on 2026-10-01. Automated pattern scan on 2026-09-30. It catches known dangerous patterns, not every risk — read a skill before letting an agent act on it.

adme-property-predictor compared with similar skills

All 4 of these similar skills score higher than adme-property-predictor; compare them before choosing.

SkillScoreStarsUpdatedFormat
adme-property-predictor (this skill)by LeoYeAI872.1k4mo agoSKILL.md
x402by browser-use100121.0k3d agoSKILL.md
algorithmic-artby anthropics100177.9k55d agoSKILL.md
pptxby anthropics100177.9k55d agoSKILL.md
designby nextlevelbuilder100149.0k6d agoSKILL.md

Frequently asked questions

How do I install adme-property-predictor?
Run npx skills add LeoYeAI/openclaw-master-skills --skill adme-property-predictor. The install tabs above show the steps for each supported agent.
Which AI agents does adme-property-predictor work with?
It is written for Universal, as a SKILL.md file. Other agents that read the same format can often use it too.
Is adme-property-predictor safe to use?
Our scan of the whole file found no instruction hijacking, hidden characters, credential access, data exfiltration or destructive commands. An AI review of the same text found nothing harmful. It is MIT-licensed and scores 98/100 on trust signals. Skills are instructions an agent will follow, so read the file before installing it and do not approve commands you do not understand.
Is adme-property-predictor still maintained?
The repository was last updated about 4 months ago. That is recent enough to be usable, but agent tooling moves fast, so check the instructions against your agent's current version.

name: adme-property-predictor description: Predict ADME (Absorption, Distribution, Metabolism, Excretion) properties for drug candidates using cheminformatics models and molecular descriptors. Evaluates drug-likeness, bioavailability, and pharmacokinetic profile to guide lead optimization and candidate selection in drug discovery. allowed-tools: [Read, Write, Bash, Edit] license: MIT metadata: skill-author: AIPOCH

ADME Property Predictor

Overview

Comprehensive pharmacokinetic prediction tool that assesses drug-likeness and ADME properties of small molecules using validated cheminformatics models, molecular descriptors, and structure-property relationships.

Key Capabilities:

  • Multi-Property Prediction: Absorption, Distribution, Metabolism, Excretion
  • Drug-Likeness Scoring: Lipinski's Rule of 5, Veber rules, QED score
  • Batch Processing: Analyze compound libraries efficiently
  • Structure-Based Insights: Identify liability hotspots and optimization opportunities
  • Comparative Analysis: Rank candidates by predicted PK profile

When to Use

✅ Use this skill when:

  • Screening compound libraries for drug-like properties in early discovery
  • Prioritizing lead compounds for advancement based on predicted PK
  • Identifying ADME liabilities requiring structural optimization
  • Comparing analogs to select candidates with optimal ADME profiles
  • Filtering virtual screening hits before synthesis
  • Generating ADME data for regulatory pre-submission packages
  • Teaching pharmacokinetics and drug design principles

❌ Do NOT use when:

  • Exact PK parameters needed for dosing → Use experimental PK studies
  • Biologics (antibodies, proteins) → Use antibody-pk-predictor
  • Natural products with complex structures → Models trained on synthetic small molecules
  • Prodrugs requiring metabolic activation → Use prodrug-activation-predictor
  • Prediction for clinical dosing decisions → CRITICAL: Experimental validation required
  • Assessing toxicity or safety → Use toxicity-structure-alert or admetox-predictor

Related Skills:

  • 上游: chemical-structure-converter (structure preparation), lipinski-rule-filter (rule-based filtering)
  • 下游: drug-candidate-evaluator (integrated scoring), molecular-dynamics-sim (detailed binding)

Integration with Other Skills

Upstream Skills:

  • chemical-structure-converter: Convert between SMILES, InChI, MOL formats
  • lipinski-rule-filter: Initial rule-based drug-likeness screening
  • chemical-structure-converter: Generate 3D conformers for structure-based predictions
  • smiles-de-salter: Remove salt counterions before analysis

Downstream Skills:

  • drug-candidate-evaluator: Multi-parameter optimization including ADME
  • toxicity-structure-alert: Assess safety alongside ADME
  • target-novelty-scorer: Evaluate target uniqueness for selected candidates
  • biotech-pitch-deck-narrative: Create investor materials with PK data

Complete Workflow:

Chemical Structure Converter (prepare structures) → 
  Lipinski Rule Filter (initial filtering) → 
    ADME Property Predictor (this skill, detailed PK) → 
      Drug Candidate Evaluator (integrated scoring) → 
        Toxicity Structure Alert (safety check)

Core Capabilities

1. Absorption (A) Prediction

Predict intestinal absorption, solubility, and permeability:

from scripts.adme_predictor import ADMEPredictor

predictor = ADMEPredictor()

# Predict absorption properties
absorption = predictor.predict_absorption(
    smiles="CC(=O)Oc1ccccc1C(=O)O",  # Aspirin
    properties=["all"]  # or specific: ["hia", "caco2", "solubility"]
)

print(absorption.summary())

Predicted Properties: | Property | Model | Units | Interpretation | |----------|-------|-------|----------------| | HIA | ML + physicochemical | % | Human intestinal absorption; >80% good | | Caco-2 | QSPR | 10⁻⁶ cm/s | Permeability; >70 high, <25 low | | Solubility | QSPR | mg/mL | Aqueous solubility; >0.1 mg/mL acceptable | | LogS | QSPR | unitless | Intrinsic solubility; >-4 acceptable | | Lipinski Pass | Rule-based | boolean | Passes all 5 rules | | Veber Pass | Rule-based | boolean | PSA <140, rotatable bonds <10 |

Best Practices:

  • ✅ Consider HIA and solubility together (high HIA but low solubility = dissolution-limited)
  • ✅ Caco-2 good for oral absorption prediction; poor for BBB penetration
  • ✅ Use both rule-based (Lipinski) and ML-based predictions for consensus
  • ✅ Check solubility at physiological pH (not just intrinsic)

Common Issues and Solutions:

Issue: Lipinski pass but poor solubility

  • Symptom: "Passes Rule of 5 but LogS = -5"
  • Solution: Lipinski checks MW and LogP, not solubility directly; use explicit solubility prediction

Issue: Caco-2 predicts high absorption but HIA low

  • Symptom: "Caco-2 = 85 (high) but HIA = 60%"
  • Solution: Models have different training sets; Caco-2 is in vitro, HIA in vivo; HIA generally more reliable

2. Distribution (D) Prediction

Predict tissue distribution, protein binding, and brain penetration:

# Predict distribution properties
distribution = predictor.predict_distribution(
    smiles="CC(=O)Oc1ccccc1C(=O)O",
    properties=["vd", "ppb", "bbb"]
)

# Access specific predictions
vd = distribution.volume_of_distribution
bbb = distribution.blood_brain_barrier
ppb = distribution.plasma_protein_binding

Predicted Properties: | Property | Model | Units | Interpretation | |----------|-------|-------|----------------| | Vd | QSPR | L/kg | Volume of distribution; 0.1-10 typical | | PPB | ML | % | Plasma protein binding; >90% high, <50% low | | BBB | LogBB | unitless | Brain penetration; >0.3 penetrant | | fu | Calculated | fraction | Free (unbound) fraction; 1 - PPB/100 |

Best Practices:

  • ✅ High PPB (>90%) may require higher doses but longer half-life
  • ✅ Low Vd (<0.3) = mainly in plasma; high Vd (>3) = extensive tissue distribution
  • ✅ BBB penetration critical for CNS drugs; avoid for peripherally-acting drugs
  • ✅ fu (free fraction) drives pharmacological activity, not total concentration

Common Issues and Solutions:

Issue: BBB predictions unreliable for certain chemotypes

  • Symptom: "BBB model gives conflicting predictions for peptides"
  • Solution: Models trained on small molecules; use specialized BBB predictors for peptides, macrocycles

Issue: PPB overestimated for acidic drugs

  • Symptom: "PPB predicted 95% but experimental is 70%"
  • Solution: Some models biased toward neutral/basic compounds; check model training set overlap

3. Metabolism (M) Prediction

Predict metabolic stability, CYP interactions, and liability sites:

# Predict metabolism properties
metabolism = predictor.predict_metabolism(
    smiles="CC(=O)Oc1ccccc1C(=O)O",
    include_site_prediction=True
)

# Check CYP interactions
cyp_profile = metabolism.cyp_profile
stability = metabolism.metabolic_stability

Predicted Properties: | Property | Model | Output | Interpretation | |----------|-------|--------|----------------| | CYP Inhibition | ML | IC50 or class | Potential DDI; <1 μM high risk | | CYP Substrate | Classification | Boolean/Probability | Metabolized by specific CYP | | Stability | ML | T1/2 or class | Microsomal/ hepatocyte stability | | Liability Sites | Reactivity models | Atom indices | Soft spots for metabolism | | MAO Substrate | Classification | Boolean | Monoamine oxidase substrate |

Best Practices:

  • ✅ Screen for CYP3A4 inhibition early (most common DDI)
  • ✅ Check if compound is CYP substrate (for polymorphism concerns)
  • ✅ Identify metabolic hotspots for structural blocking
  • ✅ Consider species differences (human vs rodent metabolism)

Common Issues and Solutions:

Issue: False negatives for time-dependent inhibition (TDI)

  • Symptom: "No CYP inhibition predicted but TDI observed experimentally"
  • Solution: Standard models predict reversible inhibition; use specialized TDI predictors

Issue: Metabolic site prediction shows multiple hotspots

  • Symptom: "5 different atoms flagged as metabolic liabilities"
  • Solution: Prioritize by reactivity score; consider blocking highest-risk site first

4. Excretion (E) Prediction

Predict clearance routes and elimination kinetics:

# Predict excretion properties
excretion = predictor.predict_excretion(
    smiles="CC(=O)Oc1ccccc1C(=O)O",
    properties=["clearance", "half_life", "route"]
)

# Access predictions
clearance = excretion.clearance_ml_min_kg
t12 = excretion.half_life_hours
route = excretion.primary_route

Predicted Properties: | Property | Model | Units | Interpretation | |----------|-------|-------|----------------| | CL | QSPR | mL/min/kg | Clearance; <5 low, 5-15 moderate, >15 high | | T1/2 | QSPR | hours | Half-life; 2-8h typical for oral drugs | | Route | Classification | renal/biliary/mixed | Primary excretion pathway | | LogD | QSPR | unitless | Distribution coefficient; affects clearance |

Best Practices:

  • ✅ Half-life determines dosing frequency (T1/2 × 5 = time to steady state)
  • ✅ Renal clearance predictable for polar compounds; hepatic less predictable
  • ✅ High clearance (>15) may require high doses or prodrug approach
  • ✅ Very long T1/2 (>24h) good for adherence but risk accumulation

Common Issues and Solutions:

Issue: Clearance predictions highly variable

  • Symptom: "Same compound, different models give CL = 5 vs 20 mL/min/kg"
  • Solution: Allometry-based methods unreliable for novel scaffolds; use average of multiple models

Issue: Route prediction contradicts structure

  • Symptom: "Highly polar compound predicted biliary, expected renal"
  • Solution: Check LogP/LogD; polar compounds (<0) usually renal; neutral/lipophilic (>1) usually hepatic

5. Integrated Drug-Likeness Scoring

Overall assessment combining all ADME properties:

# Generate comprehensive drug-likeness score
druglikeness = predictor.calculate_druglikeness(
    smiles="CC(=O)Oc1ccccc1C(=O)O",
    methods=["qed", "muegge", "golden_triangle"]
)

# Multi-parameter optimization
mpo_score = predictor.mpo_score(
    smiles="CC(=O)Oc1ccccc1C(=O)O",
    target_profile={"hia": >80, "bbb": <0.3, "t12": "2-8h"}
)

Scoring Methods: | Method | Description | Range | Good Score | |--------|-------------|-------|------------| | QED | Quantitative Estimation of Drug-likeness | 0-1 | >0.6 | | Muegge | Bioavailability score | 0-6 | >4 | | MPO | Multi-Parameter Optimization | 0-10 | >6 |

Best Practices:

  • ✅ Use QED as quick overall metric; MPO for property-weighted scoring
  • ✅ Don't rely solely on drug-likeness; efficacy and safety equally important
  • ✅ Compare to marketed drugs in same class for context
  • ✅ Track drug-likeness trends during optimization (should improve)

Common Issues and Solutions:

Issue: Drug-likeness score conflicts with project needs

  • Symptom: "CNS drug has low QED (0.5) because high LogP needed for BBB"
  • Solution: Drug-likeness rules biased toward oral drugs; use category-specific models (CNS, oncology, etc.)

6. Batch Processing and Library Screening

Analyze compound libraries efficiently:

# Batch process library
results = predictor.batch_predict(
    input_file="library.smi",  # SMILES file
    properties=["all"],
    output_format="csv",
    n_workers=4  # Parallel processing
)

# Filter by criteria
filtered = results.filter(
    lipinski_pass=True,
    hia__gt=80,
    t12__between=(2, 8)
)

# Rank by multi-parameter score
ranked = results.rank(by="mpo_score", ascending=False)

Best Practices:

  • ✅ Process in batches of 1000-10000 for memory efficiency
  • ✅ Save intermediate results (crash recovery)
  • ✅ Apply filters sequentially (Lipinski first, then detailed ADME)
  • ✅ Check property distributions to identify outliers

Common Issues and Solutions:

**Issue: Batch processing ru

Truncated for display — read the full file on GitHub.

Related Skills

View on GitHub
GitHub Stars2.1k
CategoryHealthcare
Updated3mo ago
Forks325

Languages

Python

Trust signals

98/100

From repository metadata: license, adoption, age and documentation. Not a code audit — see the Safety scan above for what the skill file itself contains.

1 info